Residency · Residency · General Surgery

Surgical Site Infections: Prevention and Management

Overview

Surgical site infections are the most common healthcare-associated infection in surgical patients, affecting 2 to 5% of those undergoing inpatient surgery. Beyond the direct clinical harm, SSIs increase morbidity, mortality, length of stay, and healthcare costs substantially. The good news is that prevention is largely achievable through multimodal, evidence-based strategies, and the general surgeon who understands these principles can meaningfully reduce infection rates in their practice.

Classification of Surgical Wounds

The CDC wound classification system stratifies surgical wounds into four classes based on the degree of contamination at the time of operation, and each class carries a predictable SSI risk. Class I (clean) wounds involve no entry into the gastrointestinal, genitourinary, or respiratory tract and no break in sterile technique, with an expected SSI rate of just 1 to 2%. Class II (clean-contaminated) wounds involve controlled entry into one of these tracts without unusual contamination, carrying a 3 to 5% infection rate. Class III (contaminated) wounds include open traumatic wounds, gross GI spillage, breaks in sterile technique, or acute inflammation, with SSI rates of 5 to 10%. Class IV (dirty/infected) wounds involve established infection, old traumatic wounds, or perforated viscera, with SSI rates exceeding 10%.

Types of Surgical Site Infections

SSIs are categorized by depth. Superficial incisional SSIs occur within 30 days of the procedure and involve only the skin and subcutaneous tissue, presenting with purulent drainage, pain, tenderness, localized swelling, or erythema. Deep incisional SSIs involve the fascia and muscle layers and may occur up to 90 days after surgery if an implant was placed; findings include purulent drainage, wound dehiscence, or an abscess identified on imaging. Organ/space SSIs involve any anatomic area that was opened or manipulated during the operation -- examples include intra-abdominal abscesses, empyema, and mediastinitis.

Microbiology

Most surgical site infections are caused by the patient's own endogenous flora. In clean wounds, the predominant organisms are Staphylococcus aureus and coagulase-negative staphylococci from the skin. In clean-contaminated and GI procedures, the microbial profile shifts to include gram-negative bacilli such as E. coli and Klebsiella, anaerobes like Bacteroides fragilis, and Enterococcus. MRSA has become increasingly prevalent, and nasal decolonization with mupirocin has demonstrated benefit in reducing MRSA-related SSIs. Fungal SSIs are rare and typically occur in the context of immunosuppression or prolonged antibiotic use.

Risk Factors

Patient-related risk factors include diabetes mellitus (particularly perioperative hyperglycemia, which is modifiable), obesity with a BMI above 30, smoking, malnutrition (albumin below 3.0 g/dL), immunosuppression from steroids, chemotherapy, or transplant medications, the presence of a remote infection at the time of surgery, prolonged preoperative hospitalization, an ASA score of 3 or higher, and advanced age.

Procedure-related risk factors include surgical duration (risk increases with each additional hour), emergency surgery, inadequate skin preparation, improper antibiotic prophylaxis timing, intraoperative hypothermia, hypoxia, excessive tissue trauma and devascularization, the presence of foreign bodies or implants, blood transfusion, and the wound classification itself.

Prevention Strategies

Preoperative

Antibiotic prophylaxis is arguably the single most impactful preventive measure. The antibiotic must be administered within 60 minutes before incision (or within 120 minutes for vancomycin and fluoroquinolones, which require longer infusion times). Cefazolin is the first-line agent for most clean and clean-contaminated procedures, dosed at 2 grams intravenously (or 3 grams for patients weighing 120 kilograms or more). For colorectal procedures and operations with anaerobic risk, cefoxitin or the combination of cefazolin plus metronidazole is appropriate. Vancomycin should be added for known MRSA colonization, prosthetic implant placement, or a high institutional MRSA rate. Intraoperative redosing is necessary when the procedure exceeds two half-lives of the antibiotic -- for cefazolin, this means redosing at four hours. Prophylactic antibiotics should be discontinued within 24 hours postoperatively; extending them beyond this window provides no additional benefit and promotes antimicrobial resistance.

The following table summarizes common antibiotic prophylaxis regimens by procedure type:

For colorectal surgery specifically, the combination of mechanical bowel preparation plus oral antibiotics (neomycin plus erythromycin or metronidazole) has been shown to reduce SSI rates. Mechanical bowel preparation alone does not.

Skin decolonization with preoperative nasal mupirocin for known S. aureus carriers (applied for five days preoperatively) and chlorhexidine body washes (two showers or wipes preoperatively) are increasingly part of universal decolonization protocols. Glycemic control should target blood glucose below 180 mg/dL perioperatively, and an HbA1c above 8% should prompt preoperative optimization. Hair removal, when necessary, should be performed by clipping immediately before surgery rather than shaving, as razors cause micro-abrasions that increase SSI risk. If hair does not interfere with the surgical field, it need not be removed at all.

Intraoperative

Chlorhexidine-alcohol skin preparation is superior to povidone-iodine for most procedures, as demonstrated by the landmark Darouiche trial in the New England Journal of Medicine. The prep must be allowed to dry completely before draping, and pooling of the flammable alcohol-based solution must be avoided. For mucous membranes, povidone-iodine remains the agent of choice because chlorhexidine is ototoxic and neurotoxic.

Maintaining normothermia (core temperature above 36 degrees Celsius) with forced-air warming blankets and warmed intravenous fluids is essential -- hypothermia impairs neutrophil function and increases blood loss. Adequate tissue oxygenation should be maintained, though the evidence for supplemental high-concentration oxygen (FiO2 of 0.8) remains debated after the PROXI trial showed no benefit and possible harm in cancer patients.

Surgical technique matters enormously. Meticulous hemostasis prevents hematomas, which serve as excellent culture media for bacteria. Tissue trauma and devascularization should be minimized. Dead space should be managed with appropriate closures rather than drains placed solely for SSI prophylaxis. Monofilament sutures have a lower infection risk than braided sutures because braided materials harbor bacteria in their interstices. Gloves should be changed after the contaminated portion of a procedure. For contaminated wounds (Class III/IV), delayed primary closure should be considered, and negative pressure wound therapy over closed incisions may reduce SSI in high-risk patients, though this evidence is still emerging.

Postoperative

Wound dressings should remain intact for the first 24 to 48 hours. Glycemic control should be maintained, early mobilization encouraged, and patients should receive appropriate wound care education.

Wound Infection Management

For superficial SSIs, the cornerstone of treatment is opening the wound and expressing purulent material. The wound drainage should be cultured, and the wound packed to heal by secondary intention. Antibiotics are usually not needed unless there is surrounding cellulitis, systemic signs of infection, or the patient is immunosuppressed.

For deep and organ/space SSIs, source control is paramount. Well-defined fluid collections can be drained by CT-guided percutaneous drainage. When percutaneous drainage is not feasible or fails, operative drainage is required. Antibiotic therapy should be directed by culture and sensitivity results. Wound VAC therapy can be valuable for managing complex wounds.

SSI Bundles and Quality Metrics

SSI prevention bundles -- standardized sets of evidence-based practices implemented together -- have proven effective at reducing infection rates. The Surgical Care Improvement Project and CMS measures focus on appropriate antibiotic selection and timing, antibiotic discontinuation within 24 hours, hair removal with clippers, perioperative normothermia, and perioperative glucose control. The ACS NSQIP program provides risk-adjusted outcomes reporting that allows benchmarking across institutions, and SSI rates are now publicly reported quality metrics.

<image>Flowchart diagram illustrating the CDC classification of surgical site infections: superficial incisional (skin and subcutaneous tissue), deep incisional (fascia and muscle), and organ/space (any anatomic area opened during surgery). Show a cross-sectional view of the abdominal wall with labeled layers (skin, subcutaneous fat, fascia, muscle, peritoneum) and colored zones indicating the depth of each SSI category.</image>

<image>Infographic-style timeline showing the optimal perioperative antibiotic prophylaxis protocol: antibiotic administration window 0-60 minutes before incision, intraoperative redosing intervals for common agents (cefazolin every 4 hours, cefoxitin every 2 hours), and discontinuation within 24 hours postoperatively. Include a comparison table of common antibiotics by procedure type.</image>

<image>Medical illustration comparing proper vs. improper skin preparation technique. Left panel: correct chlorhexidine-alcohol application with concentric circles from incision site outward, appropriate drying time. Right panel: common errors including insufficient drying time, pooling of solution, and inadequate area of preparation. Include inset showing microscopic view of skin flora being disrupted by antiseptic.</image>

Clinical Pearls

The most important modifiable risk factor for SSI is appropriate timing of prophylactic antibiotics -- administration must occur within 60 minutes of incision. Prophylactic antibiotics should be discontinued within 24 hours, as extending them beyond this point provides no additional benefit and promotes resistance. Cefazolin is the single most important drug in surgical prophylaxis, and every surgeon should know its dosing and half-life. Clipping, not shaving, is the correct method of hair removal -- or simply leaving the hair in place is equally acceptable. A superficial SSI usually requires only wound opening and drainage; antibiotics are unnecessary unless cellulitis or systemic signs are present. Perioperative hyperglycemia above 180 mg/dL significantly increases SSI risk regardless of whether the patient is diabetic. Mechanical bowel preparation alone does not reduce SSI in colorectal surgery; the combination of MBP plus oral antibiotics does. The macrophage requires a tissue pO2 of at least 30 mmHg for effective bacterial killing, which is why maintaining normothermia and adequate oxygenation are critical. MRSA nasal decolonization with mupirocin has the strongest evidence base in orthopedic and cardiac surgery. Monofilament sutures such as polydioxanone and nylon harbor fewer bacteria than braided sutures like Vicryl and silk.

References

• Ban KA, Minei JP, Laronga C, et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2017;224(1):59-74.
• Darouiche RO, Wall MJ Jr, Itani KM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362:18-26.
• Berrios-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152(8):784-791.
• Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect. 2013;14(1):73-156.

Read this lecture as Markdown